Stephen Nolan

463 total citations
18 papers, 270 citations indexed

About

Stephen Nolan is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Stephen Nolan has authored 18 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Economics and Econometrics. Recurrent topics in Stephen Nolan's work include Chronic Kidney Disease and Diabetes (13 papers), Dialysis and Renal Disease Management (8 papers) and Diabetes Treatment and Management (7 papers). Stephen Nolan is often cited by papers focused on Chronic Kidney Disease and Diabetes (13 papers), Dialysis and Renal Disease Management (8 papers) and Diabetes Treatment and Management (7 papers). Stephen Nolan collaborates with scholars based in United Kingdom, United States and Sweden. Stephen Nolan's co-authors include Juan José García Sánchez, Glen James, Roberto Pecoits‐Filho, Eric Wittbrodt, Elisabeth Sörstadius, Anna Bobrowska, Katherine R. Tuttle, Juan Jesús Carrero, David C. Wheeler and Carolyn S.P. Lam and has published in prestigious journals such as Nephrology Dialysis Transplantation, Diabetes Research and Clinical Practice and EClinicalMedicine.

In The Last Decade

Stephen Nolan

18 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Nolan United Kingdom 9 137 79 49 33 29 18 270
Salvatore Barone United Kingdom 8 207 1.5× 82 1.0× 54 1.1× 38 1.2× 39 1.3× 25 324
Laura Solá Spain 2 163 1.2× 50 0.6× 43 0.9× 22 0.7× 19 0.7× 4 390
Sana Fathima India 3 150 1.1× 34 0.4× 42 0.9× 23 0.7× 18 0.6× 9 311
Bilal Qarni Canada 4 190 1.4× 33 0.4× 37 0.8× 44 1.3× 21 0.7× 5 327
Syed Saad Canada 5 204 1.5× 34 0.4× 38 0.8× 49 1.5× 20 0.7× 23 345
Juan José García Sánchez United Kingdom 6 165 1.2× 48 0.6× 24 0.5× 32 1.0× 51 1.8× 25 260
Elisabeth Sörstadius Sweden 10 119 0.9× 155 2.0× 102 2.1× 37 1.1× 63 2.2× 21 408
Jenny Wei United States 3 140 1.0× 64 0.8× 146 3.0× 44 1.3× 13 0.4× 7 366
Judith J. Gout-Zwart Netherlands 7 154 1.1× 29 0.4× 46 0.9× 34 1.0× 57 2.0× 12 296
Titilayo O. Ilori United States 11 157 1.1× 23 0.3× 67 1.4× 55 1.7× 20 0.7× 26 410

Countries citing papers authored by Stephen Nolan

Since Specialization
Citations

This map shows the geographic impact of Stephen Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Nolan more than expected).

Fields of papers citing papers by Stephen Nolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Nolan. The network helps show where Stephen Nolan may publish in the future.

Co-authorship network of co-authors of Stephen Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Nolan. A scholar is included among the top collaborators of Stephen Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Nolan. Stephen Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tangri, Navdeep, Kook‐Hwan Oh, Jason Choo, et al.. (2025). Inside CKD: Cost-Effectiveness of Multinational Screening for CKD. Kidney International Reports. 10(4). 1087–1100. 1 indexed citations
2.
Heerspink, Hiddo J.L., Stephen Nolan, Juan Jesús Carrero, et al.. (2024). Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort. Advances in Therapy. 41(8). 3264–3277. 5 indexed citations
3.
Chertow, Glenn M., Ricardo Correa‐Rotter, Kai‐Uwe Eckardt, et al.. (2024). Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. EClinicalMedicine. 72. 102614–102614. 17 indexed citations
4.
Kiddle, Steven J., Karolina Andersson Sundell, Shira Perl, Stephen Nolan, & Magnus Bjursell. (2024). Urate‐lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink. Clinical Cardiology. 47(6). e24297–e24297. 3 indexed citations
5.
Sánchez, Juan José García, Glen James, Juan Jesús Carrero, et al.. (2023). Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort. Kidney International Reports. 8(4). 785–795. 14 indexed citations
6.
McEwan, Phil, Marco Hafner, Vivekanand Jha, et al.. (2023). Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis. Journal of Medical Economics. 26(1). 1407–1416. 3 indexed citations
7.
James, Glen, Juan José García Sánchez, Juan Jesús Carrero, et al.. (2022). Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney International Reports. 7(9). 2059–2070. 22 indexed citations
8.
9.
Pollock, Carol A., Glen James, Juan José García Sánchez, et al.. (2022). Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort. Advances in Therapy. 39(3). 1432–1445. 10 indexed citations
10.
McEwan, Phil, Juan José García Sánchez, C. David Sjöström, et al.. (2022). Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis. Nephrology Dialysis Transplantation. 38(5). 1260–1270. 11 indexed citations
11.
Pollock, Carol A., Glen James, Juan José García Sánchez, et al.. (2022). Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort. Clinical Kidney Journal. 15(11). 2124–2134. 20 indexed citations
12.
Lamerato, Lois, Juan José García Sánchez, Like Jiang, et al.. (2021). Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants. Advances in Therapy. 38(2). 1352–1363. 9 indexed citations
13.
Sánchez, Juan José García, Juliette C. Thompson, David A. Scott, et al.. (2021). Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials. Advances in Therapy. 39(1). 193–220. 22 indexed citations
14.
Sánchez, Juan José García, Alyshah Abdul Sultan, Marcelo Costa Batista, et al.. (2021). MO486INSIDE CKD: MODELLING THE IMPACT OF IMPROVED SCREENING FOR CHRONIC KIDNEY DISEASE IN THE AMERICAS AND ASIA-PACIFIC REGION. Nephrology Dialysis Transplantation. 36(Supplement_1). 1 indexed citations
15.
Bobrowska, Anna, Juan José García Sánchez, Glen James, et al.. (2020). Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review. Advances in Therapy. 38(1). 180–200. 111 indexed citations
16.
Wilding, John, Una Rigney, Betina T. Blak, et al.. (2019). Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 155. 107791–107791. 7 indexed citations
17.
Nolan, Stephen, et al.. (2013). Saving Jobs, Promoting Democracy: Worker Co-Operatives. Irish Journal of Sociology. 21(2). 103–115. 3 indexed citations
18.
McGregor, Andrew, et al.. (2012). Paracetamol use and High Anion Gap Metabolic Acidosis. Journal of the Intensive Care Society. 13(1). 54–56. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvatore Barone Breakdown of academic impact, for papers by Laura Solá Breakdown of academic impact, for papers by Sana Fathima Breakdown of academic impact, for papers by Bilal Qarni Breakdown of academic impact, for papers by Syed Saad Breakdown of academic impact, for papers by Juan José García Sánchez Breakdown of academic impact, for papers by Elisabeth Sörstadius Breakdown of academic impact, for papers by Jenny Wei Breakdown of academic impact, for papers by Judith J. Gout-Zwart Breakdown of academic impact, for papers by Titilayo O. Ilori
Rankless by CCL
2026